Biomedical Technology Solutions (BMTL) Inactive
Filed: 8 Jun 10, 12:00am
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of BioMedical Technology Solutions Holdings, Inc. (the "Company") on Form 10-Q/A-1 for the fiscal quarter ended March 31, 2010, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), we, Donald G. Cox, Principal Executive Officer/President and David A. Kempf, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
_/s/ Donald G. Cox__
Donald G. Cox
Principal Executive Officer/President
June 8, 2010
__/s/ David A. Kempf_______
David A. Kempf
Principal Financial Officer
June 8, 2010